Arkolith/Insider Trading/EYPT/Form 4

Duker Jay S.

President and CEO, DirectorEyePoint Pharmaceuticals, Inc. (EYPT) · full profile →Form 4 · filed Jul 11, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2025Option exercise(M)17K—$018K
Jul 10, 2025Tax withholding(F)8K$11.06$85K10K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 10, 2025Option exercise(M)17K—$017K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-005389) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for EyePoint Pharmaceuticals, Inc.

Build

Ask your agent about EYPT insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001562180-25-005389"
Ask your agent
Use Arkolith to summarize insider buying and selling at EyePoint Pharmaceuticals, Inc.
over the last 90 days and cite the filings.